Biotech

All Articles

Novartis sparks brand new stage of Voyager treaty with $15M capsid bargain

.Novartis levels a new outpost in its own cooperation along with Voyager Rehabs, paying for $15 mill...

Lilly blog posts more good data on its every week the hormone insulin prospect

.On the heels of an FDA rejection for its main competing Novo Nordisk, Eli Lilly is pushing on in th...

IN 8bio stops period 2 trial, gives up one-half of staff

.Only a few months after dosing the 1st patient in a period 2 trial for recently diagnosed glioblast...

Lilly, Haya ink $1B biobuck being overweight contract to search dark genome

.Eli Lilly's search for excessive weight aim ats has actually led it to the darker genome. The Big P...

ArsenalBio increases $325M, pivots off of previous lead resource

.Collection Biosciences is proceeding up. The cell therapy firm has actually added on $325 thousand ...

Lilly- backed weight management biotech files IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has actually su...

Aelis' cannabis use medicine flunks phase 2b, driving Indivior to re-think $100M possibility

.Aelis Farma's chances of protecting a simple, favorable choice on a $100 thousand option repayment ...

ProKidney standstills period 3 test certainly not required for cell treatment authorization

.ProKidney has quit one of a set of period 3 trials for its cell treatment for renal condition after...

Vaxcyte surges on 'magnificent' 31-valent PCV succeed versus Pfizer

.Vaxcyte revealed what experts named "remarkable" stage 1/2 information for its own 31-valent pneumo...

Recursion's human brain health condition test reveals little documentation of effectiveness

.Recursion has actually discovered through an early examination of its tech-enabled technique to med...